Lyra Therapeutics, Inc.LYRANASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
Year-over-Year Change
EBITDA as a percentage of revenue
Latest
-3928.42%
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-3943.13%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -3928.42% | +6.2% |
| 2023 | -4188.06% | -5.9% |
| 2022 | -3956.20% | +73.5% |
| 2021 | -14952.28% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | +100.0% |
| 2018 | -576.93% | - |